Nauka i edukacja

Eli Lilly has agreed to pay $62 million to 33 states to settle claims that it improperly marketed Zyprexa to patients who did not have schizophrenia or bipolar disorder.

At issue is whether plaintiffs have the right to sue when the products that hurt them had met federal standards.

Staten Island University Hospital has agreed to return $88.9 million that prosecutors say it fraudulently obtained from government health insurance programs.

The company is halting some pricing practices that critics say were contributing to overuse of its flagship anemia drug Aranesp at a time of mounting concerns about the product?s safety.

The company is halting some pricing practices that critics say were contributing to overuse of its flagship anemia drug Aranesp at a time of mounting concerns about the product?s safety.

The case of a 16-year-old patient with a rare form of muscular dystrophy touches on major ethical issues and is being closely watched by the pharmaceutical industry.

It is a case that pits a mother desperately seeking a medical treatment for her son against a biotechnology company for whom she claims to have worked tirelessly as an advocate.

The American Red Cross and Johnson & Johnson announced that they had settled a longstanding dispute over use of the Red Cross trademark.

The major victories for Merck pushed the litigation over Vioxx closer to conclusion and highlighted the difficulty that plaintiffs? lawyers are having in winning lawsuits against big drug companies.

The major victories for Merck pushed the litigation over Vioxx closer to conclusion and highlighted the difficulty that plaintiffs? lawyers are having in winning lawsuits against big drug companies.